Biora Therapeutics Stock (NASDAQ: BIOR) stock price, news, charts, stock research, profile.
Open | $0.611 |
Close | $0.607 |
Volume / Avg. | 150.064K / 435.611K |
Day Range | 0.600 - 0.632 |
52 Wk Range | 0.585 - 6.700 |
Market Cap | $22.795M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 8.28% |
Days to Cover | 4.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biora Therapeutics (NASDAQ: BIOR) through any online brokerage.
Other companies in Biora Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), CERo Therapeutics Hldgs (NASDAQ:CERO), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO) and Evaxion Biotech (NASDAQ:EVAX).
The latest price target for Biora Therapeutics (NASDAQ: BIOR) was reported by HC Wainwright & Co. on Tuesday, January 2, 2024. The analyst firm set a price target for 50.00 expecting BIOR to rise to within 12 months (a possible 7745.60% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Biora Therapeutics (NASDAQ: BIOR) is $0.6373 last updated Today at April 25, 2024 at 5:49 PM EDT.
There are no upcoming dividends for Biora Therapeutics.
Biora Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Biora Therapeutics.
Biora Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.